Celcuity LLC (CELC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $111.12
• Market Cap: $4.90B
• EPS: $-3.68
• 52-Week High: $120.31
• 52-Week Low: $7.58

Market Sentiment

Celcuity LLC currently has a Bullish sentiment score of 0.16.

About Celcuity LLC

Celcuity LLC is a pioneering clinical-stage biotechnology company headquartered in Minneapolis, Minnesota, dedicated to transforming cancer treatment through its cutting-edge approach to cancer subtype identification and targeted therapies. Leveraging its proprietary Celcuity technology platform, the company focuses on uncovering specific biological markers in cancer patients, facilitating personalized and effective treatment options. With a promising pipeline of drug candidates and a strong ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Celcuity LLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CELC pay dividends?

Celcuity LLC (CELC) does not currently pay a regular dividend.

What is CELC's market cap?

Celcuity LLC (CELC) has a market capitalization of $4.90B with a current stock price of $111.12.